Scholarlink

<p>Preoperative radiotherapy is a cornerstone of treatment for locally advanced rectal cancer, but intrinsic tumor cell radio resistance remains a primary obstacle limiting therapeutic efficacy. Herein, for the first time, we successfully constructed Hf<sub>0.7</sub>Ti<sub>0.3</sub>O<sub>2</sub>@PEG (HT) nanoparticles by introducing titanium (Ti) into hafnium dioxide (HfO<sub>2</sub>). These HT nanoparticles synergistically combined the superior X-ray energy deposition capability of Hf and the efficient radiation-induced ROS generation performance of Ti, leading to a 1.4-fold higher ROS yield compared to HfO<sub>2</sub>. Moreover, HT nanoparticles significantly enhanced radiosensitivity by inducing extensive DNA damage and oxidative stress in tumor cells. This resulted in a tumor inhibition rate of 87.7% ± 2.1% in mouse models. Notably, HT nanoparticles enabled a marked reduction in radiation dose while maintaining therapeutic efficacy and safety, overcoming the major limitation of conventional HfO<sub>2</sub> nanoradiosensitizers in ROS generation. This study presents a promising new approach for rectal cancer radiotherapy and holds significant potential for improving outcomes in radioresistant rectal cancer.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Engineered Hf0.7Ti0.3O2 nanoparticles for efficient radiotherapy on rectal cancer via synergistically enhanced radiation deposition and ROS production

  • 期刊论文

  • 发表日期：

    2025年9月23日

查看全文
  • Juan Du,
  • Yong-Long Ye,
  • Chao-Xiang Xie,
  • Jia-Yong Luo,
  • Kai-Wei Xu,
  • Ya-Bing Sun,
  • Liang-Xue Lai,
  • Wen-Zhi Ren,
  • Jun-Ming Guo,
  • Ai-Guo Wu,
  • Kai-Tai Liu

摘要

Preoperative radiotherapy is a cornerstone of treatment for locally advanced rectal cancer, but intrinsic tumor cell radio resistance remains a primary obstacle limiting therapeutic efficacy. Herein, for the first time, we successfully constructed Hf0.7Ti0.3O2@PEG (HT) nanoparticles by introducing titanium (Ti) into hafnium dioxide (HfO2). These HT nanoparticles synergistically combined the superior X-ray energy deposition capability of Hf and the efficient radiation-induced ROS generation performance of Ti, leading to a 1.4-fold higher ROS yield compared to HfO2. Moreover, HT nanoparticles significantly enhanced radiosensitivity by inducing extensive DNA damage and oxidative stress in tumor cells. This resulted in a tumor inhibition rate of 87.7% ± 2.1% in mouse models. Notably, HT nanoparticles enabled a marked reduction in radiation dose while maintaining therapeutic efficacy and safety, overcoming the major limitation of conventional HfO2 nanoradiosensitizers in ROS generation. This study presents a promising new approach for rectal cancer radiotherapy and holds significant potential for improving outcomes in radioresistant rectal cancer.